Maywood, Illinois Clinical Trials

A listing of Maywood, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 230 clinical trials
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

The purpose of this study is to assess the safety and efficacy of pembrolizumab (MK-3475) combination therapy in patients with metastatic castrate resistant prostate cancer (mCRPC). There will be nine cohorts in this study: Cohort A will receive pembrolizumab + olaparib, Cohort B will receive pembrolizumab + docetaxel + prednisone, …

luteinizing hormone
bone metastases
abiraterone
dexamethasone 8 mg
adenocarcinoma
Call for Information (Investigational Site 0010)
 (8.0 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +13 other locations
Trial of Andexanet in ICH Patients Receiving an Oral FXa Inhibitor

Randomized, controlled clinical trial evaluating the efficacy and safety of andexanet versus usual standard of care in patients with intracranial hemorrhage anticoagulated with a direct oral anticoagulant

Beaumont Hospital - Royal Oak
 (242.9 away) Contact site
  • 19 views
  • 17 Jul, 2021
  • +180 other locations
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active Non-Infectious Uveitis of the Posterior Segment of the Eye

This is a Phase III study to assess the efficacy and safety of DE-109 440 g every 2 months in subjects with active, non-infectious uveitis of the posterior segment of the eye (NIU-PS). There is a 6-month, single-arm, open-label period after completion of the 6-month doublemasked, controlled period allows the …

Illinois Retina Associate
 (2.9 away) Contact site
  • 126 views
  • 09 Jul, 2021
  • +89 other locations
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has begun. It is unclear if, in the relapsing phase, there is an advantage of early aggressive therapy with respect to preventing long-term disability. The infectious risks and other …

Rush University Medical Center
 (8.0 away) Contact site
  • 219 views
  • 21 Jul, 2021
  • +49 other locations
Aging and Mixed Perturbation Training to Reduce Falls in Locomotion

The long-term objective of this research is to develop an efficacious training paradigm to enhance older adults' defense mechanisms against falls and possibility reduce healthcare cost. The Centers for Disease Control and Prevention estimates the direct medical cost for fall related injuries to be $30 billion annually. Slips and trips …

University of Illinois at Chicago
 (8.0 away) Contact site
  • 58 views
  • 20 Jul, 2021
  • 1 location
Safety Tolerability and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis

The primary objective of this study is to evaluate whether cilofexor reduces the risk of fibrosis progression among non-cirrhotic adults with primary sclerosing cholangitis (PSC).

platelet count
fibrosis
cilofexor
Rush University Medical Center
 (8.0 away) Contact site
  • 83 views
  • 21 Jul, 2021
  • +231 other locations
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).

Momenta Investigational Site
 (7.7 away) Contact site
  • 15 views
  • 15 Jul, 2021
  • +138 other locations
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

Non-infectious intermediate, posterior, and panuveitides are chronic, potentially-blinding diseases. Vision-threatening cases require long-term therapy with oral corticosteroids and immunosuppression. Based upon preliminary data, adalimumab, a fully-human, anti-TNFmonoclonal antibody, now US FDA-approved for uveitis treatment, may be a superior corticosteroid-sparing agent than conventional immunosuppressive drugs. The ADVISE Trial is multicenter randomized, …

tumor necrosis factor
mycophenolate
azathioprine
small molecule
methotrexate
Rush University Medical Center
 (8.0 away) Contact site
  • 103 views
  • 11 Jul, 2021
  • +31 other locations
Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.

University of Illinois, Outpatient Care Center
 (7.7 away) Contact site
  • 0 views
  • 11 Jul, 2021
  • +45 other locations
Immune Modulators for Treating COVID-19

ACTIV-1 IM is a master protocol designed to evaluate multiple investigational agents for the treatment of moderately or severely ill patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The research objectives are to evaluate each agent with respect to speed of recovery, mortality, illness severity, and hospital resource …

University Of Illinois at Chicago
 (8.0 away) Contact site
  • 0 views
  • 11 Jul, 2021
  • +84 other locations